IRAK4-IN-7
Product Specifications
UNSPSC Description
IRAK4-IN-7 is a selective, potent and orally active interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor, extracted from patent WO2015104688 (example 1). IRAK4-IN-7 has the potential for cancer and inflammatory diseases treatment[1].
Target Antigen
IRAK
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Cancer-Kinase/protease
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/CA-4948.html
Purity
99.36
Solubility
DMSO : 13.89 mg/mL (ultrasonic)
Smiles
O=C(C1=CC=CC(C2=CC=C(N)N=C2)=N1)NC3=CN=C4C(OC(N5CCOCC5)=N4)=C3
Molecular Weight
417.42
References & Citations
[1]Venkateshwar Rao GUMMADI, et al. Bicyclic heterocyclyl derivatives as irak4 inhibitors. WO2015104688A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-109585/IRAK4-IN-7-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-109585/IRAK4-IN-7-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
1801343-74-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7069897 Inquire
Recombinant Saccharomyces cerevisiae Vacuolar membrane protein VIN13_4115 (VIN13_4115), partial
Ask
View Details 
17426124 3 x 1.0μg DNA
Cyp2j5 CRISPRa sgRNA lentivector (set of three targets)(Mouse)
Ask
View Details ![hemagglutinin (332-340) [Influenza A virus]](https://cdn.genprice.uk/genprice/genprice4.png)